SuperworthSupernus Pharmaceuticals shares outstanding SUPN
Diluted shares outstanding, averaged over each quarter, from 2011.
- Latest quarter, to Jun 30, 2026
- 58.1M
- On a year earlier
- +2.5%
- more shares
Supernus Pharmaceuticals had 58.1M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 2.5% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 57.4M | +2% |
| FY2024 | 56.5M | +2% |
| FY2023 | 55.3M | −11% |
| FY2022 | 62.1M | +14% |
| FY2021 | 54.5M | +1% |
| FY2020 | 53.8M | +0% |
| FY2019 | 53.6M | −1% |
| FY2018 | 54.1M | +1% |
| FY2017 | 53.5M | +3% |
| FY2016 | 52M | +1% |
| FY2015 | 51.5M | +20% |
| FY2014 | 42.9M | +24% |
| FY2013 | 34.6M | +30% |
| FY2012 | 26.6M | +1526% |
| FY2011 | 1.6M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 58.1M | +3% | |
| Q1 FY26 | 57.6M | +3% | |
| Q4 FY25 | 57.4M | +2% | |
| Q3 FY25 | 56.6M | +1% | |
| Q2 FY25 | 56.6M | +2% | |
| Q1 FY25 | 55.9M | +0% | |
| Q4 FY24 | 56.5M | +2% | |
| Q3 FY24 | 56M | +3% | |
| Q2 FY24 | 55.7M | +2% | |
| Q1 FY24 | 55.6M | −11% | |
| Q4 FY23 | 55.3M | −11% | |
| Q3 FY23 | 54.6M | −1% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Supernus Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.